ALB and End Stage Liver Disease: These data are congruent with prior studies that demonstrated an overall association between albumin infusion and improved survival, lesser complications, and better management of ascites, with subsequent lower length of hospitalization among patients with end-stage liver disease [19, 20, 22, 23, 48].